 |
|
|
| |
Intramuscular Injection vs Intravenous
Infusion of Ibalizumab for HTE PWH:
The Results of TMB-302
|
| |
| |
CROI 2024 March 3-6 Denver
Kaitlin R. Anstett1, R. Brandon Cash1, Anthony Mills2, Mezgebe Berhe3, Edwin DeJesus4
1Theratechnologies, Inc, Montreal, Canada, 2Men's Health Foundation, Los Angeles, CA, United States, 3North Texas Infectious Diseases Consultants, Dallas, TX, USA , 4Orlando Immunology Center, Orlando, FL, United States
|
| |
|
|
|
|
|
